Concord Biotech Limited — Board Meeting, 13-02-2025: Outcome of Board Meeting

The Board of Directors of Concord Biotech Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended December 31, 2024. The meeting will address the standalone and consolidated unaudited financials, along with insights on the company's performance for the nine months of the fiscal year. Key agenda items are expected to include revenue analysis, expenses breakdown, and strategic implications for business operations moving forward. Further details will be provided once the outcomes of the meeting are available.